← All trials
NCT03284710
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 19, 2017
- Primary completion
- Sep 30, 2019
- Completion date
- Sep 30, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 132
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- National Institute of Allergy and Infectious Diseases (NIAID)Lead sponsor
- Sanofi-AventisCollaborator
- GlaxoSmithKlineCollaborator
- University of Alabama, BirminghamStudy chair
- Centre for the AIDS Programme of Research in South AfricaStudy chair
- HIV Vaccine Trials NetworkCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.